LVOTX
Price
$20.12
Change
-$0.30 (-1.47%)
Updated
Nov 13 closing price
Net Assets
1.11B
VIMSX
Price
$78.42
Change
-$1.34 (-1.68%)
Updated
Nov 13 closing price
Net Assets
198.55B
Interact to see
Advertisement

LVOTX vs VIMSX

Header iconLVOTX vs VIMSX Comparison
Open Charts LVOTX vs VIMSXBanner chart's image
Lord Abbett Value Opportunities R5
Price$20.12
Change-$0.30 (-1.47%)
VolumeN/A
Net Assets1.11B
Vanguard Mid Cap Index Investor
Price$78.42
Change-$1.34 (-1.68%)
VolumeN/A
Net Assets198.55B
LVOTX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
LVOTX vs. VIMSX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVOTX is a Hold and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. LVOTX (1.11B). VIMSX pays higher dividends than LVOTX: VIMSX (1.38) vs LVOTX (0.21). LVOTX was incepted earlier than VIMSX: LVOTX (10 years) vs VIMSX (28 years). LVOTX (0.94) is less costly to investors than VIMSX (0.17). LVOTX is a more actively managed with annual turnover of: 33.00 vs. VIMSX (16.00). LVOTX has a lower initial minimum investment than VIMSX: LVOTX (0) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 5.67 vs. LVOTX (-10.51). VIMSX return over 5 years is better than : 52.23 vs. LVOTX (3.81).
LVOTXVIMSXLVOTX / VIMSX
Total Expense Ratio0.940.17553%
Annual Report Gross Expense Ratio0.940.17553%
Fund Existence10 years28 years-
Gain YTD1.03910.76410%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B199B1%
Annual Yield % from dividends0.211.3815%
Returns for 1 year-10.515.67-185%
Returns for 3 years11.0537.8229%
Returns for 5 years3.8152.237%
Returns for 10 years6.70148.835%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CWAN19.791.39
+7.55%
Clearwater Analytics Holdings
UBS39.600.62
+1.59%
UBS Group AG
APUS2.680.01
+0.37%
Apimeds Pharmaceuticals US Inc.
SPH18.73N/A
N/A
Suburban Propane Partners L P
SPIR8.23-0.18
-2.14%
Spire Global